Curis, Inc. (CRIS) News – Find the latest company news headlines for Curis, Inc. and all the companies you research at NASDAQ.com Curis Inc CRIS - Quotes, Financials, News, Charts and ... Curis, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948, CA-170, and CA-327. The CUDC-907 CRIS - Curis News - Barchart.com Find recent news headlines for a specific symbol on this page. Van Meerten Stock Picks. Jim Van Meerten's Daily Stock Picks highlights stocks you might want to consider for your portfolio, with Jim's editorials about current events and stock market commentary. Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. Curis, Inc. (CRIS): Price and Financial Metrics - Stock News
NASDAQ | CRIS: Stock News, Ratings & Analysis for Curis-inc
CRIS Stock Price, Forecast & News (Curis) | MarketBeat Curis's stock reverse split before market open on Wednesday, May 30th 2018. The 1-5 reverse split was announced on Tuesday, May 22nd 2018. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, May 29th 2018. CRIS: Curis Inc - Stock Price, Quote and News - CNBC Get Curis Inc (CRIS:NASDAQ) real-time stock quotes, news and financial information from CNBC. Curis, Inc. - TheStreet Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more. Forgot your password? Curis Inc. Stock Upgraded (CRIS) By TheStreet Wire. Mar 28, 2012 6:00 Why Curis, Inc. Is Soaring Today | The Motley Fool
CRIS Curis Inc. — Stock Price and Discussion | Stocktwits
Investing ideas, stock information, fundamental analysis, technical analysis on CURIS INC ($CRIS) from Singapore's largest stock investing community. Curis develops Erivedge, a capsule manufactured for the treatment of adults with skin cancer. Series Unknown Number of Employees 11-50 Legal Name Curis, Inc. IPO Status Public Stock Symbol NASDAQ:CRIS Recent News & Activity. The latest Tweets from Curis, Inc. (@CurisInc). NASDAQ: Curis Announces $30 Million Common Stock Purchase Agreement with Aspire Capital Fund, LLC
Curis, Inc. - TheStreet
Find the latest Curis, Inc. (CRIS) stock quote, history, news and other vital information to help you with your stock trading and investing. Real-time trade and investing ideas on Curis Inc. CRIS from the largest community of traders and investors. Mar 30, 2020 Get breaking news and analysis on Curis, Inc. (CRIS) stock, price quote and chart , trading and investing tools. CRIS | Complete Curis Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Find the latest news headlines from Curis, Inc. Common Stock (CRIS) at Nasdaq. com. Pipeline. Curis is focused on the development and commercialization of innovative therapeutics for the treatment of cancer.
Curis, Inc. (CRIS) News Headlines - NASDAQ.com
FinancialContent fully hosted finance channel.
Curis, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948